Cugene Inc.

2 clinical trials · Sponsor

Record	Firm	Date
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus (NCT05866861)	Cugene Inc.	2023-04-24
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers (NCT05328557)	Cugene Inc.	2021-11-09

Every clearance here is in the API, with alerts when new ones post.